The CCRM Foundation becomes top event sponsor of the Medicine by Design symposium
A reception and Therapeutic Translation poster prize will be part of the sponsorship
A reception and Therapeutic Translation poster prize will be part of the sponsorship
One-year pilot program launched with the help of a grant from Intellectual Property Ontario
Program provided an in-depth look at commercializing regenerative medicine and the life sciences ecosystem in Canada
Metformin research focuses on protecting from and repairing multiple sclerosis damage
Global and Canadian participants will come together to learn, build networks and explore the Canadian regenerative medicine ecosystem
“That’s what I’ve been doing over the past 25 years as a communications professional and educator — helping people to talk with each other and understand each other.”
Medicine by Design's EIR program a model for the successful proposal
Full day event celebrates eight years of success and explores future directions
Pitches focused on treating a difficult form of cancer and enhancing gene therapy treatments take the top spots
$25K and $10K will be awarded to the top regenerative or precision medicine innovations
Medicine by Design-funded researchers are leading the way in ground-breaking liver research
Stem cell pioneer Gordon Keller, director of the University Health Network's McEwen Stem Cell Institute, leads a team of eight labs focused on harnessing the liver’s power to regenerate. Read more.
The University of Toronto's Gary Bader, along with University Health Network researchers Sonya MacParland, and Ian McGilvray, have collaborated on a world first: generating a “map” of all cells of the human liver. Read more.
The University of Toronto's Axel Guenther’s lab has developed collagen tubes that hold potential to be developed into lab-grown bile ducts, with the aim of being able to replace this part of the organ in a patient. Read more.
Christine Bear's lab at The Hospital for Sick Children (SickKids), along with other labs, is working on treating cystic fibrosis-linked liver disease with regenerative medicine approaches. Read more.